Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Public Health England (PHE) has awarded a contract to DiaSorin for the provision of LIAISON XL associated assays, reagents and consumables used by all PHE sites.
PHE's organisational structure is currently undergoing a transformation, in addition prioritisation of the response to COVID-19 pandemic, this contract covers all DiaSorin LIAISON products currently used by PHE's Laboratories.
The contract was executed via a direct award under Lot 1(Diagnostics) of the PHE Microbiology Framework and will run until 31.03.2021 with an option to extend for 3 further periods of 12 months each.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| DiaSorin Limited | 01993990 | £1,150,000 | - |
Government spending data: This supplier has received £4,940,666 in 126 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, Guy's and St Thomas' NHS FT (2021-04-19 to 2025-11-10). View full payment history →